These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27863260)

  • 1. Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms.
    Wang J; Bettegowda C
    J Mol Diagn; 2017 Jan; 19(1):24-34. PubMed ID: 27863260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future perspectives of circulating tumor DNA in colorectal cancer.
    Nadal C; Winder T; Gerger A; Tougeron D
    Tumour Biol; 2017 May; 39(5):1010428317705749. PubMed ID: 28488528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
    Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
    Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
    Nevel KS; Wilcox JA; Robell LJ; Umemura Y
    Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.
    Saliou A; Bidard FC; Lantz O; Stern MH; Vincent-Salomon A; Proudhon C; Pierga JY
    Expert Rev Mol Diagn; 2016; 16(1):39-50. PubMed ID: 26568208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Biomarkers for Prediction of Treatment Response.
    Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
    Calapre L; Warburton L; Millward M; Ziman M; Gray ES
    Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsies for Neuroendocrine Tumors: Circulating Tumor Cells, DNA, and MicroRNAs.
    Rizzo FM; Meyer T
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):471-483. PubMed ID: 30098711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A headlight on liquid biopsies: a challenging tool for breast cancer management.
    Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A
    Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
    Strotman LN; Millner LM; Valdes R; Linder MW
    Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free circulating tumor DNA in cancer.
    Qin Z; Ljubimov VA; Zhou C; Tong Y; Liang J
    Chin J Cancer; 2016 Apr; 35():36. PubMed ID: 27056366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
    Boire A; Brandsma D; Brastianos PK; Le Rhun E; Ahluwalia M; Junck L; Glantz M; Groves MD; Lee EQ; Lin N; Raizer J; Rudà R; Weller M; Van den Bent MJ; Vogelbaum MA; Chang S; Wen PY; Soffietti R
    Neuro Oncol; 2019 May; 21(5):571-584. PubMed ID: 30668804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical role of circulating free tumor DNA in gastrointestinal malignancy.
    Howell JA; Khan SA; Knapp S; Thursz MR; Sharma R
    Transl Res; 2017 May; 183():137-154. PubMed ID: 28056336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
    Fontanilles M; Duran-Peña A; Idbaih A
    Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.
    Spindler KG
    Acta Oncol; 2017 Jan; 56(1):7-16. PubMed ID: 28010185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
    Sholl LM; Aisner DL; Allen TC; Beasley MB; Cagle PT; Capelozzi VL; Dacic S; Hariri LP; Kerr KM; Lantuejoul S; Mino-Kenudson M; Raparia K; Rekhtman N; Roy-Chowdhuri S; Thunnissen E; Tsao M; Vivero M; Yatabe Y
    Arch Pathol Lab Med; 2016 Aug; 140(8):825-9. PubMed ID: 27195432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.